Drug discovery

#Drug development #Drug discovery #Interview #ProBio #Sitting Down With #Vodcast

New vodcast: Sitting Down With… Derek Chen, ProBio

The latest episode of the DDW Sitting Down With vodcast is sponsored by ProBio, and our guest is Derek Chen, who Multimedia Editor Megan Thomas interviewed on how AI is transforming antibody drug discovery, from identifying and prioritising candidates to early developability assessment, experimental validation and the integration of discovery,… Read More

#News

#Drug development #Drug discovery #Interview #ProBio #Sitting Down With #Vodcast

Vodcast: Sitting Down With… Derek Chen, ProBio

The latest episode of the DDW Sitting Down With vodcast is sponsored by ProBio, and our guest is Derek Chen, who Multimedia Editor Megan Thomas interviewed on how AI is transforming antibody drug discovery, from identifying and prioritising candidates to early developability assessment, experimental validation and the integration of discovery,… Read More

#Videos

#BioInnovation Institute #Drug discovery #European innovation #Novo Nordisk Foundation #Start-ups

BII scales up and supports record-high number of new startups

Seventeen new companies will now benefit from BioInnovation Institute (BII)’s innovation platform, which helps companies attract capital and bring promising technologies to market. The innovation house is providing a total of around €9.5 million. Following the announcement of a new €736 million from the Novo Nordisk Foundation to the BII,… Read More

#News

#Drug activity #Drug development #Drug discovery #GPCR

Register now: Revealing hidden pharmacology with GPCR assays

The pharmacological behaviour of drugs is determined not only by their intrinsic properties but also by the sensitivity of the biological systems in which they are evaluated. Variations in receptor density and signal transduction efficiency can significantly influence observed drug responses, complicating the translation of in vitro findings to in… Read More

#News

#Drug activity #Drug development #Drug discovery #GPCR

Improving the predictive power of GPCR assays: Revealing hidden pharmacology

The pharmacological behaviour of drugs is determined not only by their intrinsic properties but also by the sensitivity of the biological systems in which they are evaluated. Variations in receptor density and signal transduction efficiency can significantly influence observed drug responses, complicating the translation of in vitro findings to in… Read More

Webinar date:
Supported by Eurofins DiscoverX
#Webinars

#Cancer research #Cancer vaccines #Drug development #Drug discovery #Immuno-oncology #Sino Biological

Summit: Advances driving immuno-oncology drug discovery

This digital summit, hosted by DDW and supported by Sino Biological, explores the advances and challenges taking place within the field of immuno-oncology. Featuring expert presentations and a panel discussion, the summit will explore topics such as how to tackle cancer drug resistance, personalised medicine, cytotoxic therapy in the immunotherapy… Read More

#News

#Cancer research #Cancer vaccines #Drug development #Drug discovery #Immuno-oncology #Sino Biological

The advances driving immuno-oncology drug discovery

This digital summit, hosted by DDW and supported by Sino Biological, explores the advances and challenges taking place within the field of immuno-oncology. Featuring expert presentations and a panel discussion, the summit will explore topics such as how to tackle cancer drug resistance, personalised medicine, cytotoxic therapy in the immunotherapy… Read More

Webinar date:
Sponsored by Sino Biological
#Webinars

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (21-25 September 2026) 

News round-up for 21-25 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Digital Forum and the Drug Discovery Innovators & Investors Conference in London, as well as the latest developments in drug discovery,… Read More

#News

#Drug discovery #Drug discovery events #Events #UK

Six reasons to register for Drug Discovery Innovators & Investors UK Conference

Early bird rates for the Drug Discovery Innovators & Investors (DDII) UK Conference close on 30 September 2026. Taking place on 4 November 2026 at etc.venues Monument in London, UK, the conference brings together pharma and biotech companies, technology suppliers, academia, start-ups, spin-outs and investors for a focused day of… Read More

#News